Table 1.
Mendelian Genes that Lead to Parkinsonism and Their Pathology
Locus | Genes | Clinical Features | Pathology |
---|---|---|---|
Dominant | |||
PARK1/4 | α-Synuclein | Typical PD but can sometimes have a dementia presentation | Lewy bodies |
PARK8 | LRRK2 | Typical PD | Usually Lewy bodies: sometime tangles, sometimes neither |
FTDP-17 | MAPT | Most mutations have a dementia phenotype but some have a typical PD presentation | Tau/tangle pathology |
SCA3 | Ataxin3 | Usually ataxia in Europeans, but often Parkinsonian especially in Africans | Probably not Lewy bodies. Probably polyglutamine inclusions |
SCA2 | Ataxin2 | Usually ataxia in Europeans, but often Parkinsonian especially in Asians | Probably not Lewy bodies. Probably polyglutamine inclusions |
Recessive | |||
PARK2 | Parkin | Very slowly progressive early onset disease usually with sleep benefit | Usually not Lewy bodies |
PARK6 | PINK1 | Usually very slowly progressive early onset disease usually with sleep benefit | One case with Lewy bodies |
PARK7 | DJ-1 | Little data, but seems similar to parkin | Not known |
PARK9 | ATP13A2 | Aggressive and complex parkinsonism with many additional features | Not known |
PARK14 | PLA2G6 | Aggressive and complex parkinsonism with many additional features | Lewy bodies |
SPG11 | Spatacsin | Usually spastic paraplegia but sometimes aggressive and complex parkinsonism with additional features | Not known |
High-Risk Locus | |||
Gaucher's (1) locus | GBA | Typical PD | Lewy bodies |
Low-Risk Loci | |||
SNCA | Typical PD | Lewy bodies | |
MAPT | Lewy bodies (though tau pathology not systematically assessed | ||
LRRK2 | Typical PD | Lewy bodies | |
HLA | Typical PD | Lewy bodies |